Publications by authors named "Ute Berger"

Claim this Profile
E
Explaining survival differences between two consecutive studies with allogeneic stem cell transplantation in patients with chronic myeloid leukemia.
Markus Pfirrmann, Susanne Saussele, Andreas Hochhaus, Andreas Reiter, Ute Berger

J Cancer Res Clin Oncol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The European LeukemiaNet: achievements and perspectives.
Rüdiger Hehlmann, David Grimwade, Bengt Simonsson, Jane Apperley, Michele Baccarani, Ute Berger

Haematologica· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia.
Rüdiger Hehlmann, Ute Berger, Markus Pfirrmann, Hermann Heimpel, Andreas Hochhaus

Blood· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Clinical research within the German competence net "acute and chronic leukemias"].
Susanne Saussele, Ute Berger, Carlo Aul, Thomas Büchner, Hartmut Döhner

Med Klin (Munich)· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic myeloid leukemia: a model for oncology.
Rüdiger Hehlmann, Ute Berger, Andreas Hochhaus

Ann Hematol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up.
Tanja Lahaye, Birte Riehm, Ute Berger, Peter Paschka, Martin C Müller

Cancer· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2.
Andreas Reiter, Christoph Walz, Ann Watmore, Claudia Schoch, Ilona Blau, Brigitte Schlegelberger, Ute Berger

Cancer Res· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Normalization of previously shortened telomere length under treatment with imatinib argues against a preexisting telomere length deficit in normal hematopoietic stem cells from patients with chronic myeloid leukemia.
Tim H Brummendorf, Inci Ersoz, Ulrike Hartmann, Stefan Balabanov, Holger Wolke, Ute Berger

Ann N Y Acad Sci· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telomere length in peripheral blood granulocytes reflects response to treatment with imatinib in patients with chronic myeloid leukemia.
Tim H Brümmendorf, Inci Ersöz, Ulrike Hartmann, Kerol Bartolovic, Stefan Balabanov, Ute Berger

Blood· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Drug therapy of chronic myeloid leukemia].
Andreas Hochhaus, Ute Berger, Andreas Reiter, Tanja Lahaye, Sebastian Kreil

Med Klin (Munich)· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis